Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
J Exp Med. 2021 Jun 7;218(6). doi: 10.1084/jem.20210444.
Advances in genome sequencing have resulted in the identification of the causes for numerous rare diseases. However, many cases remain unsolved with standard molecular analyses. We describe a family presenting with a phenotype resembling inherited thrombocytopenia 2 (THC2). THC2 is generally caused by single nucleotide variants that prevent silencing of ANKRD26 expression during hematopoietic differentiation. Short-read whole-exome and genome sequencing approaches were unable to identify a causal variant in this family. Using long-read whole-genome sequencing, a large complex structural variant involving a paired-duplication inversion was identified. Through functional studies, we show that this structural variant results in a pathogenic gain-of-function WAC-ANKRD26 fusion transcript. Our findings illustrate how complex structural variants that may be missed by conventional genome sequencing approaches can cause human disease.
基因组测序的进展已经确定了许多罕见疾病的病因。然而,许多病例在经过标准的分子分析后仍然无法解决。我们描述了一个表现出类似于遗传性血小板减少症 2 (THC2)表型的家族。THC2 通常是由单核苷酸变异引起的,这些变异会阻止 ANKRD26 表达在造血分化过程中沉默。短读长全外显子组和基因组测序方法无法在这个家族中鉴定出一个致病变体。使用长读长全基因组测序,鉴定出一个涉及配对重复倒位的大型复杂结构变异。通过功能研究,我们表明这种结构变异导致了致病性的 WAC-ANKRD26 融合转录本。我们的研究结果说明了复杂的结构变异可能会导致人类疾病,而这些结构变异可能会被传统的基因组测序方法所遗漏。